oxidopamine has been researched along with Dysembryoma in 3 studies
Oxidopamine: A neurotransmitter analogue that depletes noradrenergic stores in nerve endings and induces a reduction of dopamine levels in the brain. Its mechanism of action is related to the production of cytolytic free-radicals.
oxidopamine : A benzenetriol that is phenethylamine in which the hydrogens at positions 2, 4, and 5 on the phenyl ring are replaced by hydroxy groups. It occurs naturally in human urine, but is also produced as a metabolite of the drug DOPA (used for the treatment of Parkinson's disease).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Moon, J | 1 |
| Schwarz, SC | 1 |
| Lee, HS | 1 |
| Kang, JM | 1 |
| Lee, YE | 1 |
| Kim, B | 1 |
| Sung, MY | 1 |
| Höglinger, G | 1 |
| Wegner, F | 1 |
| Kim, JS | 1 |
| Chung, HM | 1 |
| Chang, SW | 1 |
| Cha, KY | 1 |
| Kim, KS | 1 |
| Schwarz, J | 1 |
| Chang, YL | 1 |
| Chen, SJ | 1 |
| Kao, CL | 1 |
| Hung, SC | 1 |
| Ding, DC | 1 |
| Yu, CC | 1 |
| Chen, YJ | 1 |
| Ku, HH | 1 |
| Lin, CP | 1 |
| Lee, KH | 1 |
| Chen, YC | 1 |
| Wang, JJ | 1 |
| Hsu, CC | 1 |
| Chen, LK | 1 |
| Li, HY | 1 |
| Chiou, SH | 1 |
| Parish, CL | 1 |
| Parisi, S | 1 |
| Persico, MG | 1 |
| Arenas, E | 1 |
| Minchiotti, G | 1 |
3 other studies available for oxidopamine and Dysembryoma
| Article | Year |
|---|---|
Preclinical Analysis of Fetal Human Mesencephalic Neural Progenitor Cell Lines: Characterization and Safety In Vitro and In Vivo.
Topics: Animals; Biomarkers; Cell Culture Techniques; Cell Line; Cell Proliferation; Disease Models, Animal; | 2017 |
Docosahexaenoic acid promotes dopaminergic differentiation in induced pluripotent stem cells and inhibits teratoma formation in rats with Parkinson-like pathology.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Apoptosis; Cells, Cultured; Docosahexaenoic A | 2012 |
Cripto as a target for improving embryonic stem cell-based therapy in Parkinson's disease.
Topics: Animals; Brain; Brain Neoplasms; Cell Differentiation; Dopamine; Embryo, Mammalian; Epidermal Growth | 2005 |